おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
AFYX Therapeutics
company
About
AFYX Therapeutics is a clinical stage biopharmaceutical company
- Copenhagen,Hovedstaden,Denmark
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €16.20M
- Industries
- Biotechnology,Clinical Trials,Delivery,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Also Known As
- Dermtreat ApS
AFYX Therapeutics is changing the way mucosal diseases are treated. They are a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options. Their proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. Designed with electrospinning technology, it delivers a therapeutic directly to the site in need, without interfering with patients’ daily activities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€16.27M $13M
AFYX Therapeutics has raised a total of
€16.27M $13M
in funding over 2 rounds. Their latest funding was raised on
Jun 24, 2019 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 24, 2019 | Debt Financing | $13M | 2 | — | — | Detail |
| Jan 1, 2019 | Grant | €71.42K | 1 | — | — | Detail |
| May 9, 2017 | Series A | €16.20M | 3 |
Lundbeckfonden Emerge
Novo Holdings
Sofinnova Investments
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
4
AFYX Therapeutics is funded by 4 investors.
Sofinnova Investments
and Lundbeckfonden Emerge
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sofinnova Investments
|
Yes | Series A |
|
Lundbeckfonden Emerge
|
— | Debt Financing |
|
Novo Holdings
|
— | Debt Financing |
EASME - EU Executive Agency for SMEs
|
— | Grant |
Employee Profiles
Number of Employee Profiles
5
AFYX Therapeutics has 5 current employee profiles, including
Executive LARS SIIM MADSEN
Executive
Executive
Executive
Board member
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
